SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-041676
Filing Date
2021-08-05
Accepted
2021-08-05 16:49:18
Documents
87
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bbio-10q_20210630.htm   iXBRL 10-Q 4312479
2 EX-31.1 bbio-ex311_9.htm EX-31.1 22025
3 EX-31.2 bbio-ex312_8.htm EX-31.2 22098
4 EX-32.1 bbio-ex321_7.htm EX-32.1 11841
5 EX-32.2 bbio-ex322_6.htm EX-32.2 11542
  Complete submission text file 0001564590-21-041676.txt   16124362

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bbio-20210630.xsd EX-101.SCH 104503
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bbio-20210630_cal.xml EX-101.CAL 83037
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bbio-20210630_def.xml EX-101.DEF 402893
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bbio-20210630_lab.xml EX-101.LAB 736450
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bbio-20210630_pre.xml EX-101.PRE 587123
11 EXTRACTED XBRL INSTANCE DOCUMENT bbio-10q_20210630_htm.xml XML 3529243
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38959 | Film No.: 211149114
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences